Class information for:
Level 1: ADENOVIRAL MEDIATED INTERFERON ALPHA//GENE IMMUNE MED//CANC BIOL 173

Basic class information
ID Publications Average number
of references		 Avg. shr. active
ref. in WoS
19736 427 36.9 79%


Bar chart of Publication_year

Last years might be incomplete

Classes in level above (level 2)


ID, lev.
above		 Publications Label for level above
892 10711 JOURNAL OF INTERFERON RESEARCH//ISG15//JOURNAL OF INTERFERON AND CYTOKINE RESEARCH

Terms with highest relevance score


Rank Term Type of term Relevance score
(tfidf)		 Class's shr.
of term's tot.
occurrences		 Shr. of publ.
in class containing
term		 Num. of
publ.
in class
1 ADENOVIRAL MEDIATED INTERFERON ALPHA Author keyword 6 100% 1% 4
2 GENE IMMUNE MED Address 3 42% 1% 5
3 CANC BIOL 173 Address 3 28% 2% 8
4 SECT STUDIES HOST IMMUNE PONSE Address 3 28% 2% 8
5 GELPART Author keyword 2 67% 0% 2
6 ADENOVIRAL MEDIATED INTERFERON ALPHA TREATMENT Author keyword 1 100% 0% 2
7 CATIONIC MULTILAMELLAR LIPOSOMES Author keyword 1 100% 0% 2
8 GELATIN CONJUGATION Author keyword 1 100% 0% 2
9 INTEGRATED BIOL SCI PROGRAM Address 1 50% 0% 2
10 UNIT 0018 5 Address 1 100% 0% 2

Web of Science journal categories

Author Key Words


Rank Web of Science journal category Relevance score
(tfidf)		 Class's shr.
of term's tot.
occurrences		 Shr. of publ.
in class containing
term		 Num. of
publ.
in class		 LCSH search Wikipedia search
1 ADENOVIRAL MEDIATED INTERFERON ALPHA 6 100% 1% 4 Search ADENOVIRAL+MEDIATED+INTERFERON+ALPHA Search ADENOVIRAL+MEDIATED+INTERFERON+ALPHA
2 GELPART 2 67% 0% 2 Search GELPART Search GELPART
3 ADENOVIRAL MEDIATED INTERFERON ALPHA TREATMENT 1 100% 0% 2 Search ADENOVIRAL+MEDIATED+INTERFERON+ALPHA+TREATMENT Search ADENOVIRAL+MEDIATED+INTERFERON+ALPHA+TREATMENT
4 CATIONIC MULTILAMELLAR LIPOSOMES 1 100% 0% 2 Search CATIONIC+MULTILAMELLAR+LIPOSOMES Search CATIONIC+MULTILAMELLAR+LIPOSOMES
5 GELATIN CONJUGATION 1 100% 0% 2 Search GELATIN+CONJUGATION Search GELATIN+CONJUGATION
6 HUMAN INTERFERON BETA 1 22% 1% 4 Search HUMAN+INTERFERON+BETA Search HUMAN+INTERFERON+BETA
7 72 KD GELATINASE 1 50% 0% 1 Search 72+KD+GELATINASE Search 72+KD+GELATINASE
8 ADENOVIRAL MEDIATED TRANSFER 1 50% 0% 1 Search ADENOVIRAL+MEDIATED+TRANSFER Search ADENOVIRAL+MEDIATED+TRANSFER
9 ANTIGEN SPECIFIC CD8 T CELL 1 50% 0% 1 Search ANTIGEN+SPECIFIC+CD8+T+CELL Search ANTIGEN+SPECIFIC+CD8+T+CELL
10 EMBOLIC EFFECT 1 50% 0% 1 Search EMBOLIC+EFFECT Search EMBOLIC+EFFECT

Key Words Plus


Rank Web of Science journal category Relevance score
(tfidf)		 Class's shr.
of term's tot.
occurrences		 Shr. of publ.
in class containing
term		 Num. of
publ. in
class
1 FRIEND LEUKEMIA CELLS 9 43% 4% 17
2 CATIONIC MULTILAMELLAR LIPOSOMES 8 100% 1% 5
3 RNA HYBRIDIZATION TECHNIQUE 7 32% 4% 19
4 OVERCOMES RESISTANCE 7 57% 2% 8
5 MEDIATED SYSTEMIC DELIVERY 7 67% 1% 6
6 NUDE MOUSE BRAIN 5 60% 1% 6
7 SYSTEMIC IMMUNITY 5 24% 4% 18
8 CAUSES REGRESSION 4 56% 1% 5
9 GELATINASE PRODUCTION 4 36% 2% 8
10 CARCINOEMBRYONIC ANTIGEN PRODUCTION 3 60% 1% 3

Journals

Reviews


Title Publ. year Cit. Active
references		 % act. ref.
to same field
Phase I Trial of Intravesical Recombinant Adenovirus Mediated Interferon-alpha 2b Formulated in Syn3 for Bacillus Calmette-Guerin Failures in Nonmuscle Invasive Bladder Cancer 2013 7 21 52%
Interferon-alpha in tumor immunity and immunotherapy 2002 195 93 34%
Interferon-beta gene therapy for cancer: Basic research to clinical application 2004 52 24 54%
Role of type I interferon in inducing a protective immune response: Perspectives for clinical applications 2015 1 55 20%
Endogenous type I interferons as a defense against tumors 2002 57 37 49%
Wherefore interferon? 1997 58 50 32%
Interferon-alpha as Antiviral and Antitumor Vaccine Adjuvants: Mechanisms of Action and Response Signature 2012 10 71 17%
Treatment with low-dose interferon-alpha restores the balance between matrix metalloproteinase-9 and E-cadherin expression in human transitional cell carcinoma of the bladder 2001 40 92 26%
Cytokines as a link between innate and adaptive antitumor immunity 2002 171 56 11%
Perioperative IFN-alpha a to avoid surgically induced immune suppression in colorectal cancer patients 2006 14 54 22%

Address terms


Rank Address term Relevance score
(tfidf)		 Class's shr.
of term's tot.
occurrences		 Shr. of publ.
in class containing
term		 Num. of
publ.
in class
1 GENE IMMUNE MED 3 42% 1.2% 5
2 CANC BIOL 173 3 28% 1.9% 8
3 SECT STUDIES HOST IMMUNE PONSE 3 28% 1.9% 8
4 INTEGRATED BIOL SCI PROGRAM 1 50% 0.5% 2
5 UNIT 0018 5 1 100% 0.5% 2
6 YAGI MEM PK 1 18% 1.2% 5
7 CELL BIOL 173 1 33% 0.5% 2
8 RECH BIOMED CRODELIERS 1 50% 0.2% 1
9 SOC AZIONI 1 50% 0.2% 1
10 HEMATOL ONCOL MOL THER EUT 1 19% 0.7% 3

Related classes at same level (level 1)


Rank Relatedness score Related classes
1 0.0000204208 INTERFERON RECEPTOR//IFNAR2//IFNAR1
2 0.0000116247 ORAL PROTEINS//IFR Y1221//UPR 9045 CNRS
3 0.0000104369 JOURNAL OF INTERFERON RESEARCH//TEXAS REPORTS ON BIOLOGY AND MEDICINE//JOURNAL OF BIOLOGICAL RESPONSE MODIFIERS
4 0.0000098804 ADV CELL MOL THER Y//SHUNDE PEOPLES HOSP//TUMOR VACCINE
5 0.0000088708 BIOL GENET BACTERIAL CELL WALL//FC GAMMA RIII ALPHA//HUMAN INJECTIONS
6 0.0000075496 TUMOR TROPISM//MOL NEUROTHER Y IMAGING//VET BIOCHEM IMMUNOL
7 0.0000073726 BRAIN TUMOR PROGRAM//GLIOMA IMMUNOTHER Y GRP//GL261
8 0.0000069416 TUMOR GRAFT//MACROTRANSFECTION//MINITRANSFECTION
9 0.0000065924 RNASE L//2 5A//SECT BIOMED CHEM
10 0.0000059358 BIOCHEMOTHERAPY//METASTATIC MELANOMA//DACARBAZINE